共 6 条
[1]
A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis[J] . TiloHenseler,KarlheinzSchmitt‐Rau.International Journal of Dermatology . 2008 (10)
[2]
Measures used in specifying psoriasis lesion（s）, global disease and quality of life: A systematic review[J] . Javier Garduno,Monali J. Bhosle,Rajesh Balkrishnan,Steven R. Feldman.Journal of Dermatological Treatment . 2007 (4)
[3]
Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment[J] . Richard G. Langley,Charles N. Ellis.Journal of the American Academy of Dermatology . 2004 (4)
[4]
Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-γ and IL-4 expression in psoriatic skin in situ
[J].
ARCHIVES OF DERMATOLOGICAL RESEARCH,
2003, 294 (12)
:559-562
Piskin, G
;
Heydendael, VMR
;
de Rie, MA
;
Bos, JD
;
Teunissen, MBM
.
[5]
The MOS 36-ltem Short-Form Health Survey （SF-36）: I. Conceptual Framework and Item Selection[J] . John E. Ware,Cathy Donald Sherbourne.Medical Care . 1992 (6)
[6]
Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis[J] . M. A. Rie,F. Hamerlinck,R. Q. Hintzen,J. D. Bos,R. A. W. Lier.Archives of Dermatological Research . 1991 (8)